Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoid Tumor”

234 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 234 results

Not applicableEnrolling By InvitationNCT02270567
What this trial is testing

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

Who this might be right for
Neuroendocrine TumorCarcinoidNeuroendocrine Carcinoma
Wren Laboratories LLC 400
Not applicableLooking for participantsNCT05756608
What this trial is testing

Fibrosis in Chronic and Delayed Myocardial Infarction

Who this might be right for
Aortic StenosisChemotherapy Induced Systolic DysfunctionCarcinoid Syndrome
University of Edinburgh 180
Testing effectiveness (Phase 2)Study completedNCT00965250
What this trial is testing

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Who this might be right for
ThymomaThymic CarcinomaThymic Carcinoid+1 more
National Cancer Institute (NCI) 49
Not applicableStudy completedNCT00303901
What this trial is testing

Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Barbara Ann Karmanos Cancer Institute 40
Large-scale testing (Phase 3)Study completedNCT00774930
What this trial is testing

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 115
Testing effectiveness (Phase 2)Study completedNCT01327612
What this trial is testing

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Who this might be right for
Advanced Solid TumorsCarcinoidColorectal Cancer+6 more
Amgen 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03950609
What this trial is testing

Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors

Who this might be right for
Advanced Carcinoid TumorDigestive System Neuroendocrine NeoplasmMultiple Endocrine Neoplasia Type 1+2 more
M.D. Anderson Cancer Center 36
Not applicableEnded earlyNCT01130363
What this trial is testing

Fundic Gland Polyps and Proton Pump Inhibitor (PPI) Drugs

Who this might be right for
Fundic Gland Polyps
Columbia University 23
Early research (Phase 1)WithdrawnNCT04602117
What this trial is testing

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Who this might be right for
HER2-positive Breast CancerHER2 LowSYD-985+24 more
QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)UnknownNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 44
Very early researchWithdrawnNCT03623984
What this trial is testing

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Carcinoma of PancreasCarcinoid
University of Alabama at Birmingham
Not applicableLooking for participantsNCT04735198
What this trial is testing

Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.

Who this might be right for
Midgut Carcinoid TumorBiliary Stones
Hospital Universitari de Bellvitge 100
Testing effectiveness (Phase 2)Study completedNCT02259725
What this trial is testing

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
University of Southern California 3
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00843531
What this trial is testing

RAD001 and Erlotinib in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
University of California, San Francisco 17
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Not applicableStudy completedNCT00416689
What this trial is testing

Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer

Who this might be right for
Breast CancerLung CancerNausea and Vomiting
Alliance for Clinical Trials in Oncology 99
Testing effectiveness (Phase 2)Active Not RecruitingNCT05361668
What this trial is testing

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Testing effectiveness (Phase 2)WithdrawnNCT04776876
What this trial is testing

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Who this might be right for
Advanced Neuroendocrine NeoplasmCarcinoid Syndrome
M.D. Anderson Cancer Center
Load More Results